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G€osta B. Pettersson, MD, PhD,b and David P. Mason, MD,b Cleveland, OhioRecent experience with donation after cardiac death
(DCD) for lung transplantation has been excellent.1
Despite this fact, use of DCD donors has been limited be-
cause of concerns that graft quality may be compromised.
As an additional barrier to widespread acceptance, DCD
procurement is shrouded with technical concerns, specif-
ically regarding the timing of heparin administration. Pre-
arrest systemic heparinization during DCD procurements
is not a consistent policy among centers because of the
fear that heparin might accelerate death. Despite any ev-
idence, most transplant centers decline DCD lungs for
fear of thromboembolism if procured heparin free.2 To ad-
dress this specific concern, DCD lungs declined for trans-
plantation because of lack of systemic heparin were
harvested and examined for gross and microscopic
thrombosis.
CLINICAL SUMMARY
A 40-year-old man sustained irreversible neurologic in-
jury from a drug overdose. He did not meet brain death cri-
teria, but the family consented him for Maastricht Category
III organ donation. Because the hospital DCD protocol did
not permit systemic heparinization before withdrawal of
care, all national transplant centers declined the lungs,
which were procured for research.FIGURE 1. Map of lung sectioning for microscopic analysis.During the DCD procurement, cardiac arrest occurred
70 minutes after withdrawal of care and extubation. After
5 minutes of electrocardiographic silence, the donor wasrdiovascular Surgery c Volume 145, Number 5 e49
FIGURE 2. Hematoxylin–eosin stainingof a representative lung sectionwithnomicrovascular thrombi at 2.53magnification (A) and1003magnification (B).
Case Reportsreintubated and the lungs reinflated.Concomitantly, amidline
sternotomy was performed and the pleural cavities were
packed with ice. After cannulation of the pulmonary artery,
the heart was exsanguinated and the left atrial appendage ex-
cised. Three liters of ice-chilled Perfadex (Vitrolife, Kungs-
backa, Sweden) preservation solution enriched with 50,000
IU heparin were flushed antegrade through the pulmonary ar-
tery. After standard en bloc lung extirpation, an additional 1 L
was flushed retrograde through the pulmonary vein ostia. Ef-
fluent was collected and examined for gross clot. The lungs
were transported on ice and fixed subsequently in 10% for-
malin at physiologic pressure (18 mm Hg). Each lung was
cut in 5-mm sagittal sections and analyzed systematically
from apex to base for gross occlusive clot. In addition, a total
of 20 tissue sections (10 sections per lung) were collected
from the right and left lung (Figure 1) for microscopic exam-
ination. Each tissue section was paraffin embedded and
stained with hematoxylin–eosin. A pulmonary pathologist
evaluated each tissue section for microvascular thrombi
with 100 high-power fields (HPFs), resulting in a total evalu-
ation of 2000 HPFs for the complete lung.
Evaluation of the antegrade and retrograde effluent re-
vealed no significant clot formation. Gross macroscopic as-
sessment of each sagittal plane found no occlusive central
or peripheral clot. Microscopic analysis revealed no micro-
vascular thrombi in the alveolar capillaries or pulmonary
vasculature in any HPF (0/2000). Focal areas of acute
pneumonia were identified. Representative histology at
12.53 and 1003 magnification is presented in Figure 2.
DISCUSSION
The first human lung transplantation was performed us-
ing a DCD donor who was heparinized after cardiac death.
Although the standard protocol in the United States is to ad-
minister heparin before withdrawal of care,2 some centers
restrict heparin until after cardiac standstill because of eth-
ical concerns about hastening death. Although pathologic
correlates of heparin-free DCD procurement have not
been described previously, the vast majority of thesee50 The Journal of Thoracic and Cardiovascular Surgpotential donor lungs are declined for fear of postmortem
thrombosis.
In this study, we demonstrated complete absence of gross
and microvascular thrombi in human lungs that did not re-
ceive heparin before declaration of death. Despite the ex-
tended agonal phase of 70 minutes in this donor, no clot
formation was identified when the lungs were retrieved
and flushed with heparinized pulmoplegia. This supports
our recent experimental findings of delayed heparin admin-
istration in a pig DCD model, in which it appears that hep-
arin can be administered at least 25 minutes after cardiac
standstill without the formation of gross or microvascular
thrombi in the lungs.3
Potential explanations of this lack of thrombosis after
DCD arrest are as follows: (1) passive circulation after car-
diac arrest continues for several minutes as a result of an in-
trinsic gradient between the systemic arterial and central
venous pressures,4 (2) the period between cardiac arrest
and organ procurement is brief, and (3) antegrade and retro-
grade flushing with heparinized pulmoplegia effectively
eliminates any residual blood.5
We conclude that nonheparinized Maastricht Category
III DCD human lungs do not appear to harbor thrombi
when harvested using antegrade and retrograde flush en-
riched with heparin. Although further investigation is war-
ranted, evidence suggests that these organs can be used
without concern for thromboembolism.
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